Abstract
Purpose
To strengthen the recognition of mucinous tubular and spindle cell carcinomas of the kidney (MTSCC-Ks) by analyzing CT and MR imaging findings of MTSCC-Ks.
Materials and methods
This study retrospectively enrolled ten patients with pathologically confirmed MTSCC-Ks from 2007 to 2020. The main observed imaging characteristics included growth pattern, signal characteristics on T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI), hemorrhage, necrosis, cystic degeneration, lipid component, pseudocapsule and the enhancement pattern. Apparent diffusion coefficient (ADC) value of MTSCC-Ks and normal renal cortex were measured, respectively. All imaging features were evaluated in consensus by two genitourinary radiologists.
Results
All patients (53.1 ± 6.5 years, male to female, 3:7) presented with a solitary renal tumor with the mean diameter of 3.5 ± 0.4 cm. All lesions showed iso- or slight hypoattenuation on non-contrast CT with no hemorrhage but cystic degeneration (10%) and necrosis (10%). On T2WI, all lesions showed predominantly slight hypointensity with focal hyperintensity. The ADC value of MTSCC-Ks was 0.845 ± 0.017 × 10−3 mm2/s, and ADCtumor-to-ADCrenal cortex value was 0.376 ± 0.084. Pseudocapsules existed in all MTSCC-Ks on MRI. There were seven lesions showed heterogeneous enhancement, while three lesions showed homogeneous enhancement. Among them, six MTSCC-Ks showed slight multiple patchy enhancement (60%) in the corticomedullary phase, while the remaining MTSCC-Ks showed homogeneously slight enhancement (30%) or slightly stratified enhancement (10%). All MTSCC-Ks exhibited slow and progressive enhancement in the late phases.
Conclusion
Iso- or slight hypoattenuation on CT, slight hypointensity with focal hyperintensity on T2WI, marked diffusion restriction on DWI and ADC map, slight multiple patchy enhancement in the corticomedullary phase, and slow and progressive enhancement in the late phases are the imaging features of MTSCC-Ks, which may facilitate the diagnosis of MTSCC-Ks.
Similar content being viewed by others
Data availability
The datasets used during this study are available from the corresponding author on reasonable request.
References
Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. WHO classification of the renal tumors of the adults. Eur Urol. 2006;49:798–805. https://doi.org/10.1016/j.eururo.2005.11.035.
Kenney PA, Vikram R, Prasad SR, Tamboli P, Matin SF, Wood CG, Karam JA. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes. BJU Int. 2015;116:85–92. https://doi.org/10.1111/bju.12992.
Ged Y, Chen Y-B, Knezevic A, Donoghue MTA, Carlo MI, Lee C-H, et al. Mucinous tubular and spindle-cell carcinoma of the kidney: clinical features, genomic profiles, and treatment outcomes. Clin Genitourin Cancer. 2019;17:268-274.e1. https://doi.org/10.1016/j.clgc.2019.04.006.
Bai HS, Wang D, Shou JZ, Li CL, Xing NZ. Renal mucinous tubular and spindle cell carcinoma of the kidney: a report of 5 cases and literature review. Oncol Prog. 2019;17:1716–21. https://doi.org/10.11877/j.issn.1672-1535.2019.17.14.28.
Kay FU, Pedrosa I. Imaging of solid renal masses. Urol Clin North Am. 2018;45:311–30. https://doi.org/10.1016/j.ucl.2018.03.013.
Zhao M, He X-L, Teng X-D. Mucinous tubular and spindle cell renal cell carcinoma: a review of clinicopathologic aspects. Diagn Pathol. 2015;10:168. https://doi.org/10.1186/s13000-015-0402-1.
Dhillon J, Amin MB, Selbs E, Turi GK, Paner GP, Reuter VE. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change. Am J Surg Pathol. 2009;33:44–9. https://doi.org/10.1097/PAS.0b013e3181829ed5.
Kuroda N, Hes O, Michal M, Nemcova J, Gal V, Yamaguchi T, Kawada T, Imamura Y, Hayashi Y, Lee GH. Mucinous tubular and spindle cell carcinoma with Fuhrman nuclear grade 3, A histological, immunohistochemical, ultrastructural and FISH study. Histol Histopathol. 2008;23:1517–23. https://doi.org/10.14670/HH-23.1517.
Fine SW, Argani P, DeMarzo AM, Delahunt B, Sebo TJ, Reuter VE, Epstein JI. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am J Surg Pathol. 2006;30:1554–60.
Thway K, Du Parcq J, Larkin JMG, Fisher C, Livni N. Metastatic renal mucinous tubular and spindle cell carcinoma. Atypical behavior of a rare, morphologically bland tumor. Ann Diagn Pathol. 2012;16:407–10. https://doi.org/10.1016/j.anndiagpath.2011.04.001.
Gong P, Zhuang Q, Wang X, Xu R, Ding T, Yin S, He X. Mucinous tubular and spindle cell carcinoma of the kidney: five case reports and review of the literature. Oncol Lett. 2020;20:337. https://doi.org/10.3892/ol.2020.12201.
Cornelis F, Ambrosetti D, Rocher L, Derchi LE, Renard B, Puech P, et al. CT and MR imaging features of mucinous tubular and spindle cell carcinoma of the kidneys. A Multi-Inst Rev Eur Radiol. 2016;27:1087–95. https://doi.org/10.1007/s00330-016-4469-1.
Takahashi H, Vikram R, Jimenez RE, Bolan CW, Kawashima A, Karam JA, Takahashi N. MR characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: comparison with clear cell and papillary subtypes of renal cell carcinoma. Abdom Radiol (NY). 2021. https://doi.org/10.1007/s00261-021-03227-0.
Sahni VA, Hirsch MS, Sadow CA, Silverman SG. Mucinous tubular and spindle cell carcinoma of the kidney: imaging features. Cancer Imaging. 2012;12:66–71. https://doi.org/10.1102/1470-7330.2012.0008.
Kang SK, Huang WC, Pandharipande PV, Chandarana H. Solid renal masses: what the numbers tell us. AJR Am J Roentgenol. 2014;202:1196–206. https://doi.org/10.2214/AJR.14.12502.
Nicolau C, Antunes N, Paño B, Sebastia C. Imaging Characterization of Renal Masses. Medicina (Kaunas). 2021. https://doi.org/10.3390/medicina57010051.
Venkatesh R, Weld K, Ames CD, Figenshau SR, Sundaram CP, Andriole GL, et al. Laparoscopic partial nephrectomy for renal masses: effect of tumor location. Urology. 2006;67:1169–74. https://doi.org/10.1016/j.urology.2006.01.089 (discussion 1174).
Konijn LCD, van Overhagen H, Takx RAP, de Jong PA, Veger HTC, Mali WPTM. CT calcification patterns of peripheral arteries in patients without known peripheral arterial disease. Eur J Radiol. 2020;128:108973. https://doi.org/10.1016/j.ejrad.2020.108973.
Ho VB, Allen SF, Hood MN, Choyke PL. Renal masses: quantitative assessment of enhancement with dynamic MR imaging. Radiology. 2002;224:695–700. https://doi.org/10.1148/radiol.2243011048.
Silverman SG, Israel GM, Herts BR, Richie JP. Management of the incidental renal mass. Radiology. 2008;249:16–31. https://doi.org/10.1148/radiol.2491070783.
Yu X, Lin M, Ouyang H, Zhou C, Zhang H. Application of ADC measurement in characterization of renal cell carcinomas with different pathological types and grades by 3.0T diffusion-weighted MRI. Eur J Radiol. 2012;81:3061–6. https://doi.org/10.1016/j.ejrad.2012.04.028.
Wang H, Cheng L, Zhang X, Wang D, Guo A, Gao Y, Ye H. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. Radiology. 2010;257:135–43. https://doi.org/10.1148/radiol.10092396.
Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182:844–53. https://doi.org/10.1016/j.juro.2009.05.035.
Paudyal B, Paudyal P, Tsushima Y, Oriuchi N, Amanuma M, Miyazaki M, et al. The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J Radiol. 2010;83:336–43. https://doi.org/10.1259/bjr/74949757.
Parwani AV, Husain AN, Epstein JI, Beckwith JB, Argani P. Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation. Hum Pathol. 2001;32:506–12. https://doi.org/10.1053/hupa.2001.24320.
Nathany S, Monappa V. Mucinous tubular and spindle cell carcinoma: a review of histopathology and clinical and prognostic implications. Arch Pathol Lab Med. 2020;144:115–8. https://doi.org/10.5858/arpa.2017-0506-RS.
Srigley JR, Delahunt B, Eble JN, et al. The international society of urological pathology (ISUP) vancouver classification of renal neoplasia. Am J Surg Pathol. 2013;37:1469–89. https://doi.org/10.1097/PAS.0b013e318299f2d1.
Wu X, Chen Y, Sha J, Zhao L, Huang J, Bo J-J, et al. Renal mucinous tubular and spindle cell carcinoma: a report of 8 cases and review of the literature. Diagn Pathol. 2013;8:206. https://doi.org/10.1186/1746-1596-8-206.
Min J, Zhang GP, Wang Y, Liu GP, Gu CY, Wang XB. Clinicopathologic analysis of kidney mucinous tubular and spindle cell carcinoma. J Chengdu Med Coll. 2019;14:375–9. https://doi.org/10.3969/j.issn.1674-2257.2019.03.024.
Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours. Eur Urol. 2016;70:93–105. https://doi.org/10.1016/j.eururo.2016.02.029.
Cornelis F, Ambrosetti D, Rocher L, Derchi LE, Renard B, Puech P, et al. CT and MR imaging features of mucinous tubular and spindle cell carcinoma of the kidneys. A Multi-Inst Rev Eur Radiol. 2017;27:1087–95. https://doi.org/10.1007/s00330-016-4469-1.
Noon AP, Smith DJ, McAndrew P. Magnetic resonance imaging characterization of a mucinous tubular and spindle cell carcinoma of the kidney detected incidentally during an ectopic pregnancy. Urology. 2010;75:247–8. https://doi.org/10.1016/j.urology.2009.09.047.
Zhu Q, Zhu W, Wang Z, Wu J. Clinical and CT imaging features of mucinous tubular and spindle cell carcinoma. Chin Med J. 2014;127:1278–83.
Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 2013;267:444–53. https://doi.org/10.1148/radiol.13112617.
Cornelis F, Tricaud E, Lasserre AS, Petitpierre F, Bernhard JC, Le Bras Y, et al. Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours. Eur Radiol. 2014;24:1068–80. https://doi.org/10.1007/s00330-014-3107-z.
Acknowledgements
None.
Funding
National Natural Science Foundation of China (No. 81971580); National Natural Science Foundation of China (No. 81471641).
Author information
Authors and Affiliations
Contributions
HK: data acquisition and analysis, literature search, methodological advice, formal analysis, manuscript preparation, manuscript editing, critical revision of the manuscript. WX: manuscript preparation, manuscript editing, systematic search process, methodological advice. SC: data analysis, methodological advice. JY: systematic search process, methodological advice, pathological analysis. XB: systematic search process, methodological advice. JZ: data acquisition, systematic search process. HG: data acquisition and analysis. HY: concept, methodological advice. HW: concept, Supervision, Project administration, Funding acquisition, manuscript review. All authors declare to have approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (approval number: S2021-103–01).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kang, H., Xu, W., Chang, S. et al. Mucinous tubular and spindle cell carcinomas of the kidney (MTSCC-Ks): CT and MR imaging characteristics. Jpn J Radiol 40, 1175–1185 (2022). https://doi.org/10.1007/s11604-022-01294-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-022-01294-x